ADVISORY RESEARCH INC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$2,866,820
-53.6%
52,362
-28.8%
0.40%
-49.7%
Q2 2023$6,175,553
+105.2%
73,536
+85.0%
0.79%
+60.0%
Q1 2023$3,010,192
+185.4%
39,749
+132.6%
0.50%
+400.0%
Q4 2022$1,054,794
+218.7%
17,090
+115.5%
0.10%
+209.4%
Q3 2022$331,0007,9290.03%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders